Trials / Unknown
UnknownNCT04606082
Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI
Intra Uterine Injection of Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor at Ovum Pick up Day Significantly Increase Implantation Rate and Pregnancy Rate in Intra Cytoplasmic Sperm Injection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Intrauterine Granulocyte colony stimulating factor (GCSF) was compared with intrauterine Human Chorionic Gonadotropin (HCG) in increasing clinical pregnancy rate as a primary outcome and ultrasound imaging of gestational sac as a secondary outcome.
Detailed description
Two hundred females with history of recurrent implantation failure and undergoing Intracytoplasmic Sprem injection (ICSI) were randomized into two groups; the first group (100 patients) received intrauterine Granulocyte colony stimulating factor (GCSF) and the second group (100) received intrauterine Human Chorionic Gonadotropin (HCG) at ovum pick up day. The clinical pregnancy rate was evaluated as a primary outcome after 14 days and ultrasound imaging of gestational sac was evaluated as a secondary outcome after 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Granulocyte Colony Stimulated Factor | GCSF was intrauterine injected once at ovum pick up day |
| DRUG | Human Chorionic Gonadotropins | 500 IU of HCG was injected intrauterine once at ovum pick up day |
Timeline
- Start date
- 2020-10-30
- Primary completion
- 2021-01-10
- Completion
- 2021-01-10
- First posted
- 2020-10-28
- Last updated
- 2020-10-28
Source: ClinicalTrials.gov record NCT04606082. Inclusion in this directory is not an endorsement.